XRCC1‐Arg/Gln genotype indicated a 3.1‐fold increased risk of BC in pre‐menopausal patients (p = 0.001) while XPG‐His/His genotype showed a 1.2‐fold increased risk in younger BC patients (<40 years) (p = 0.028). Here, ERCC5 is linked to breast cancer.